Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

Breast cancer may be detectable through changes in scalp hair lipids.

Biopsy is crucial to accurately distinguish Erosive Pustular Dermatosis of the Scalp from Squamous Cell Carcinoma.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Promising cancer treatments were found, but the manufacturer closed.

Early diagnosis and treatment of SLE are crucial to prevent severe complications.

Laparoscopic surgery is safe and effective for colon cancer, with benefits like less blood loss and shorter hospital stays.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Proper periodontal treatment with xenograft effectively manages aggressive periodontitis in SLE patients.

Surgical excision is the best treatment for SCC.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The procedure effectively improved facial appearance with high satisfaction and low complications.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Repeated left stellate ganglion blocks may improve skin elasticity, water content, and hair follicle density on the treated side.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

The "spade sign" is a highly specific indicator for diagnosing acne keloidalis.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.